RGABX
Price
$77.29
Change
-$0.25 (-0.32%)
Updated
Jun 2 closing price
Net Assets
337.53B
USLCX
Price
$29.73
Change
-$0.30 (-1.00%)
Updated
Jun 2 closing price
Net Assets
1.27B
Interact to see
Advertisement

RGABX vs USLCX

Header iconRGABX vs USLCX Comparison
Open Charts RGABX vs USLCXBanner chart's image
RGABX vs USLCX Comparison Chart in %
View a ticker or compare two or three
VS
RGABX vs. USLCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGABX is a Hold and USLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 338B vs. USLCX (1.27B). RGABX (0.00) and USLCX (0.00) have matching dividends . RGABX was incepted earlier than USLCX: RGABX (24 years) vs USLCX (24 years). USLCX (1.89) is less costly to investors than RGABX (1.38). RGABX (32.00) and USLCX (32.00) have comparable annual turnover. RGABX has a lower initial minimum investment than USLCX: RGABX (250) vs USLCX (1000). RGABX annual gain was more profitable for investors over the last year : 12.61 vs. USLCX (-31.77). RGABX return over 5 years is better than : 16.44 vs. USLCX (-41.79).
RGABXUSLCXRGABX / USLCX
Total Expense Ratio1.381.8873%
Annual Report Gross Expense Ratio1.381.8973%
Fund Existence24 years24 years-
Gain YTD10.079-0.826-1,221%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets338B1.27B26,551%
Annual Yield % from dividends0.000.00-
Returns for 1 year12.61-31.77-40%
Returns for 3 years45.92-26.43-174%
Returns for 5 years16.44-41.79-39%
Returns for 10 years92.60-16.49-562%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSHAX12.600.20
+1.61%
NYLI Cushing® MLP Premier Class A
RYOAX61.16N/A
N/A
Rydex Biotechnology H
SWTSX18.32N/A
N/A
Schwab Total Stock Market Index
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
JLPYX25.76N/A
N/A
JPMorgan US Large Cap Core Plus R6